A new pharmaceutical concept for the treatment of oropharyngeal and oesophageal candidosis with fluconazole

Administration of fluconazole in capsule form has proved effective in the prophylaxis and treatment of mucosal candidosis, particularly in immunosuppressed patients. An additional topical effect in oropharyngeal and oesophageal candidosis might be expected with a fluconazole suspension. This hypothe...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Mycoses 1996-09, Vol.39 (9-10), p.357-360
Hauptverfasser:	Wildfeuer, A., Laufen, H., Yeates, R. A., Zimmermann, T.
Format:	Artikel
Sprache:	eng
Schlagworte:	Administration, Oral Adult Antibiotics. Antiinfectious agents. Antiparasitic agents Antifungal agents Antifungal Agents - administration & dosage Antifungal Agents - pharmacokinetics Antifungal Agents - therapeutic use antifungals antimycotic chemotherapy Antimykotika antimykotische Chemotherapie Biological and medical sciences Candida Candidiasis - drug therapy Candidiasis, Oral - drug therapy Candidose Candidosis Capsules Cross-Over Studies Female Fluconazol fluconazole Fluconazole - administration & dosage Fluconazole - pharmacokinetics Fluconazole - therapeutic use Human mycoses Humans Infectious diseases Male Medical sciences Middle Aged Mycoses Mycoses of the digestive system oesophagus oropharynx pharmacoknetics Pharmacology. Drug treatments Pharmakokinetik saliva Saliva - metabolism Speichel Suspensions
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!